Predictors of the quality of life in Chinese breast cancer survivors
Little is known about the importance of various factors which impair the quality of life (QOL) in survivors of breast cancer 1 year after diagnosis and over 1 year after diagnosis in China. Hence, the goal of this article is to quantitatively evaluate the factors which play an active role in impairing QOL 1 year after diagnosis and over 1 year after diagnosing survivors.
A population-based cross-sectional study was conducted at 34 Cancer Recovery Clubs across China from May 2014 to January 2015. The simplified Chinese version of the Quality of Life Questionnaire-Core 30 items (EORTC QLQ-C30) and the Breast Cancer-specific module QLQ-23 were used to measure QOL in 10794 Chinese women with breast cancer (1 year after diagnosis: 1029, over 1 year after diagnosis: 9765). Forward stepwise multivariable regression analysis was used to identify the most predictive factors for limitations on QOL. Partial R 2 values were calculated to appraise the independent proportion of explained variance within QOL by each factor included in the model.
The participants had higher scores of role functioning, sexual function, sexual enjoyment, and financial difficulties. The uppermost predictors of functional status and QOL were financial difficulties and fatigue for the 1 year after diagnosis, respectively, and fatigue, financial difficulties, and systemic side effects for the long-term survivors. These symptoms explained approximately 28–53% of the variability within the function scores and QOL expect for sexual enjoyment and sexual functioning. Although sociodemographic and clinical factors had a relative importance to sexual function and sexual enjoyment, they were even smaller and had less of an impact on other dimensions.
People who were more active and had an optimistic attitude towards life had relatively higher function scores. For the breast cancer patients 1 year after diagnosis, reducing the burden of fatigue might be a more preferable way to improve their functional status and QOL. Nevertheless, focusing on fatigue symptoms and systemic therapy side effects synchronously may present an especially worthwhile endeavor to enhance the long-term survivors’ functional status and QOL.
KeywordsBreast cancer 1 year after diagnosis Long-term survivors QOL Impact
We thank the study participants and the research staff for their contribution to this project.
Compliance with ethical standards
Conflict of interest
The authors declare no potential conflicts of interest.
- 1.World Health Organization (2017) http://www.who.int/mediacentre/factsheets/fs297/en/
- 3.Coyne P, Navidi M, Wuchukwu OI (2011) Survivorship in breast cancer—factors affecting quality of life. Eur J Surg Oncol 37:986–987Google Scholar
- 10.Ward MA (2013) Factors affecting quality of life in breast cancer survivors. Proceedings: 9th annual symposium: graduate research and scholarly projects. Wichita State University, Wichita, pp 10–11Google Scholar
- 11.Bernhard J, Hürny C, Coates AS, Peterson HF, Castiglionegertsch M, Gelber RD, Galligioni E, Marini G, Thürlimann B, Forbes JF (1998) Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG). Br J Cancer 78:686–693CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Irukulla M, Vaghmare R, Joseph D, Ahmed SF, Jonnadula J, Valiyaveettil D (2016) Impact of comorbidities on quality of life in breast cancer patients. Indian J Cardiovasc Dis J women (IJCD) 1:1–5Google Scholar
- 18.Dodd MJ, Cho MH, Bank KA, Cooper BA, Lee KA, Miaskowski C (2005) Impact of Symptom Clusters on Quality of Life (QOL) Dimensions in Breast Cancer Patients. In: 16 th International Nursing Research CongressGoogle Scholar
- 21.Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (2005) The European Organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI 85:365–376CrossRefGoogle Scholar
- 22.Sprangers MA, Groenvold M, Arraras JI, Franklin J, Te VA, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P (1996) The European Organization for research and treatment of cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol 14:2756CrossRefPubMedGoogle Scholar
- 23.Tang Z, Wang JW, Zhang QY, Sun L, Tang FR, Kang M, Yu JM (2015) QLQ-BR23 and EORTC QLQ-C30 for the measurement of the impact of rehabilitation exercise on quality of life in breast cancer patients. Fudan Univ J Med Sci 42:589–595Google Scholar
- 24.Fayers PM, Aaronson NK, Bjordal K (2001) The EORTC QLQ-C30 scoring manual. EORTC Data Center, BrusselsGoogle Scholar
- 25.Scott NW, Fayers PM, Aaronson NK, Bottomley A, De Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Mirjam AG Sprangers on behalf of the EORTC Quality of Life Group (2008) EORTC QLQ-C30 Reference values. EORTC Quality of Life Study Group. pp 1–427Google Scholar
- 28.Kim HJ (2007) Symptom prevalence and intensity in breast cancer patients receiving treatment. In: The 18th International Nursing Research Congress Focusing on Evidence-Based PracticeGoogle Scholar
- 30.Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, Abernethy AP (2013) The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist 18:381–390. doi: 10.1634/theoncologist.2012-0279 CrossRefPubMedPubMedCentralGoogle Scholar